Saint-Julien-en-Genevois, France

Franck Gueneau

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Franck Gueneau: Innovator in Monoclonal Antibodies

Introduction

Franck Gueneau is a notable inventor based in Saint-Julien-en-Genevois, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 6 patents to his name, Gueneau's work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Gueneau's latest patents include innovative advancements in monoclonal antibodies. One of his key inventions is related to anti-CD3 epsilon antibodies and methods of use thereof. This patent discloses monoclonal antibodies and antigen binding fragments that specifically bind CD3 epsilon, along with methods for their production and application in various therapeutic, diagnostic, and prophylactic contexts. Another significant patent focuses on methods for generating multispecific and multivalent antibodies. This invention provides novel bispecific monoclonal antibodies with different specificities for each binding site, along with methods for their production and purification.

Career Highlights

Franck Gueneau is currently associated with Novimmune SA, a company known for its focus on developing innovative antibody-based therapies. His work at Novimmune has allowed him to explore and expand the potential of monoclonal antibodies in medical applications.

Collaborations

Gueneau collaborates with esteemed colleagues such as Nicolas Fischer and Ulla Ravn. Their combined expertise contributes to the advancement of research and development in the field of monoclonal antibodies.

Conclusion

Franck Gueneau's contributions to the field of biotechnology, particularly in monoclonal antibodies, highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…